Join
Live feed
·
PRReleasevia Quantisnow
Orgenesis Inc. logo

Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic

ByQuantisnow·Wall Street's wire, on your screen.
ORGS· Orgenesis Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORGS (Orgenesis Inc.) and more on Quantisnow.